PVI, PeerView Institute for Medical Education

cme meded oncology hematology moc immunotherapy cne neurology pulmonology cpe lung cancer nsclc pathology immuno-oncology ncpd ce cancer lymphoma immunology primary care dermatology medical education cardiology peerview allergy gastroenterology multiple sclerosis breast cancer radiology rheumatology immune checkpoint inhibitors endocrinology patient care acute myeloid leukemia urology prostate cancer liver cancer hepatocellular carcinoma diabetes asthma chronic lymphocytic leukemia pediatrics hcc egfr leukemia cll multiple myeloma surgery rcc biomarkers renal cell carcinoma kidney cancer pancreatic cancer aml precision medicine checkpoint blockade parp inhibitors emergency medicine cc mantle cell lymphoma btk inhibitors t2dm bladder cancer ophthalmology gastric cancer hepatology ovarian cancer asco novel therapeutics internal medicine ms targeted therapy her2 atopic dermatitis lcsm b-cell malignancies checkpoint inhibitors hematology-oncology heart failure immune checkpoint inhibitor ipf tnbc pembrolizumab atezolizumab interstitial lung disease mcl family practice family medicine jak inhibitors idiopathic pulmonary fibrosis psoriasis durvalumab colorectal cancer osimertinib pd-l1 myeloma car-t myelofibrosis nivolumab pulmonary fibrosis sclc radiation oncology genetics psychiatry io asco18 melanoma type 2 diabetes radiation therapy nursing ild stroke small cell lung cancer tkis glp-1 ras thoracic surgery biomarker doacs vte hemophilia parp follicular lymphoma bmt tandem 2018 asco 2018 gastrointestinal cancers bcl-2 inhibitors antibody–drug conjugates surgical oncology tumor treating fields non-hodgkin lymphoma ttfields diffuse large b-cell lymphoma tki immune-related adverse events biomarker testing lungcancer migraine severe asthma sma disease-modifying therapies veno-occlusive disease disease-modifying therapy head and neck cancer acute lymphoblastic leukemia cholangiocarcinoma ipilimumab hct vod radiotherapy pd-1 patient health gastrointestinal cancer chemotherapy urothelial carcinoma gene therapy adaura dupilumab bcma dmt direct oral anticoagulants asco20 bcsm esophageal cancer diabetic macular edema pi3k inhibitors diabetic retinopathy antibody therapy molecular testing hcsm gej cancer oncology nursing nephrology gbm glioblastoma uncontrolled asthma blood cancer atrial fibrillation bcell prep epilepsy asco19 gi cancers iraes venous thromboembolism parp inhibitor mds all immunooncology myelodysplastic syndromes sinusoidal obstruction syndrome american thoracic society nontuberculousmycobacteria ntm evidence-based medicine type 2 diabetes mellitus chronic kidney disease anemia respirology pharmacy cmv amyotrophic lateral sclerosis eosinophilic esophagitis nvaf asco17 ckd managed care scchn checkpoint inhibitor ascvd als hyperlipidemia bladder preservation trk fusions dlbcl liraglutide semaglutide hcv gastroesophageal junction cancer neuro-oncology neurofibromatosis hiv prevention plexiform neurofibromas endometriosis non-small cell lung cancer gvhd ngs resectable melanoma gynecology myeloproliferative neoplasms multidisciplinary team tardive dyskinesia tenosynovial giant cell tumors non–small cell lung cancer knowaml spinal muscular atrophy asco21 rheumatoid arthritis proliferative diabetic retinopathy trop2 her3 anti-angiogenic agents radiation tgct veliparib prostatecancer t-dxd niraparib irae olaparib egfr tki trastuzumab sarcoma axspa triple-negative breast cancer precision oncology mesothelioma brca hematopoietic cell transplantation stroke prevention mobocertinib cme/moc egfr testing imars type2diabetes oral anticoagulants ici mcrpc major depressive disorder crc anticoagulation geriatrics sos nasal polyposis t2d cancer immunotherapies systemic lupus erythematosus endometrial cancer sle benralizumab sglt2 inhibitors mepolizumab fgfr transplant inflammatory bowel disease cytomegalovirus influenza general practice hyperkalemia copd infectious diseases lupus obesity hiv infectious disease autologous stem cell transplant mri cancer diagnosis dw-mri opioid car-t cell ct angiography ash17 vegf ct perfusion graft-versus-host disease epidermal growth factor receptor genomic testing exon 20 insertions poziotinib gi18 amivantamab liquid biopsy lgs nf1 extensive-stage small cell lung cancer lennox-gastaut syndrome es-sclc impower133 curesma nonproliferative diabetic retinopathy caspian avelumab otolaryngology aflibercept gu18 ranibizumab eye care bevacizumab tyrosine kinase inhibitor type 1 diabetes movement disorders hodgkin lymphoma low-grade gliomas malignant peripheral nerve sheath tumors adjuvant osimertinib renalcellcarcinoma solidtumor infectiousdiseases ruxolitinib transplant surgery immune-mediated adverse reactions b-cell lymphoma immunoonc nonvalvular atrial fibrillation ash18 aha18 ascp2018 noacs btk inhibitor b cell b-cell egpa hf fgfr inhibitors allogeneic hct b-cell nhl hnc kidneycancer ibrutinib car t therapy doaç multikinase inhibitor internalmed secondary aml genitourinary cancer solid tumor car-t cell therapy onscongress cne meded imids immune-related adverse effects btk oncologic emergencies infectiousdisease rucaparib breastcancer diabetic kidney disease obstetrics #cme uterine fibroids #moc fibroids #cne #cpe patient education niemann-pick disease bmt axial spondyloarthritis asthma and immunology american academy of allergy large hemispheric infarction lhi noncontrast ct american academy of dermatology gastroesophageal cancer nhl ats2018 homologous recombination afib ons congress phenylketonuria pku #cme #moc #cc #cne #immunotherapy #nsclc #io #onco neoadjuvant adjuvant dvt macular degeneration tremelimumab go2foundation checkpoint inhibition cervical cancer gynecologic cancer cdk4/6 dementia-related psychosis pegaspargase pediatric hematology-oncology mpn trastuzumab emtansine hepatitis c neratinib crpc spms rrms margetuximab sti multidisciplinary care entrectinib sexual health internalmedicine american diabetes association adcs ilna larotrectinib myeloprotection parp inhibition transcription inhibition omalizumab recombinant crisantaspase pseudomonas fluorescens erwinia chrysanthemi asparaginase rc-p abim moc solid tumors blood-based screening shared decision-making ers polycythemia vera european respiratory society weight loss md lurbinectedin incretin-based pharmacotherapy topotecan etoposide heart failure society of america weight-loss medication enzyme replacement therapy carboplatin hsct pharmacist diabetes mellitus btk resistance insulin lirentelimab warfarin crohn's disease ra ulcerative colitis chf ibd ad cpe meded alzheimer's disease venetoclax infection amyloidosis alzheimer's ankylosing spondylitis ash 2017 chronic pain trk opioids interstitiallungdisease selpercatinib calcineurin inhibitors transplantation primarycare pain management hepatitis biliarycancer anti-angiogensis american society of clinical oncology annual meeti randomized clinical trials real-world data lixisenatide dulaglutide glp-1 biliary cancers gallbladder cancer biliary tract cancers il-17 inhibitors immune checkpoint blockade paclitaxel sitc brain metastases parkinson's disease psoriaticarthritis idh and to apply for credit stem cell transplant depression marginal zone lymphoma chair nurses mtc2019 tct 2019 follicular-lymphoma mantle-cell-lymphoma aapm35 solid-organ transplant solo 2 chronic-lymphocytic-leukemia urothelial cancer solo 1 aua19 lenalidomide cisplatin chemo-immunotherapy trilaciclib thoracic19 chronic rhinosinusitis il-13 small lymphocytic lymphoma il-13 inhibitors aaaai 2019 sll il-4 infigratinib azathioprine #glt2 acmg 19 kidneydisease #cme #cne #moc #aats #aats2019 #nsclc #lungcancer cyclosporine pacific methotrexate il-31 inhibitors keynote-799 ecog-acrin 5181 checkmate -816 asbrs pemigatinib backpain ons solid tumor ons congress 2019 btkinhibitors tnfi corticosteroids biliary tract cancer nsaid phototherapy aad 2019 ivosidenib mycophenolate mofetil lymsm thermosensitive drug carriers mwa microwave ablation rfa radiofrequency ablation anti-angiogenesis agents multikinase inhibitors emergency nursing 2019 ena19 imaes imae imar immune-mediated adverse events imminology immunomodulating drugs next-generation antibodies fl malignant pleural mesothelioma glioblastoma multiforme solid malignancies glucagon-like peptide-1 receptor agonists opg chest2019 urticaria atopicdermatitis endhiv preventhiv hivprevention pn pediatric oncology talazoparib ras/mapk genomics de novo ph+ aml high-risk aml flt3 aml-mrc cabozantinib whole brain radiation therapy stereotactic radiosurgery srs wbrt rt thromboprophylaxis stroma targeted brca-mutant locally advanced metastatic thrombocytopenia low-molecular-weight heparin gastroentrology lmwh dalteparin casebook immunomodulating agents palliative care flt3-mutated aml flt3 inhibitors aanam systemicsclerosis postremission therapy ats2019 chemoradiation hnscc crisaborole cap19chi glucagon-like peptide-1 rad onc bacterial infections critical care exenatide patient-centered care seizures ada 2021 cardiovascular outcomes trials cvots cancer-associated vte (cat) deep venous thrombosis elderly patients relapsed/refractory myeloma smoldering myeloma idl thoracic malignancies thoracic cancers ttf pulmonary embolism pe jakinhibitor basal insulin pep obgyn rpc4046 ak002 seud2018 metastatic colorectal cancer mcrc colon cancer lysosomal disorders budesonide acid sphingomylinase deficiency eosinophils fluticasone etrasimod society of interventional radiology sir18la fingolimod world allergy organization ozanimod ponesimod siponimod sphingosine-1-phosphate receptor modulator cmsc18 cmsc aua 2018 aua18 nurse soft tissue sarcoma low back pain back pain acmg 2018 acmgmtg18 motor neuron disease deep vein thrombosis mnd motor neurone disease prurigo nodularis metastatic crc arrs18 arvo2018 wet amd amd advanced crc cme pancsm fenebrutinib biib091 dr dme vision-threatening complications intravitreal treatments retinal disease anti-vegf adult vaccination immunization vaccination pneumococcal disease pneumococcal vaccines work sdm american academy of ophthalmology aao ada tumors stage i-iii lung cancer oncologic surgery aaaai 2018 aad 2018 alemtuzumab natalizumab ocrelizumab ofatumumab teriflunomide asct interferon β 1-a pd-1 checkpoint inhibition bmttandem18 pd-l1 checkpoint inhibitor cemiplimab-rwlc myasthenia gravis hncs18 hncsm rms ppms bruton tyrosine kinase bruton tyrosine kinase inhibitor evobrutinib pacritinib sno2018 inflammation atherosclerosis aats2018 pcsk9 inhibitors cholesterol momelotinib mental health cap18 luspatercept navitoclax astro18 pelabresib ana2018 cpi-0610 img-7289 cicon18 bomedemstat imetelstat acep18 chest2018 hematopoietic stem cell transplantation hematopoietic cell transplant tct meetings 2019 gu19 post transplant graft-versus-host-disease masterclass case forum ptcl amcpnexus cap18chi ctos2018 b-cell cancer suo18 systemic juvenile idiopathic arthritis sjia juvenile arthritis opioid epidemic opioid crisis livermtg18 jaki fedratinib pulmonary arterial hypertension pulmonary hypertension immuno-onc aacr18 myosin inhibitors glaucoma sarcomere mutations let's win letswinpc american heart association american college of cardiology hfsa hfsa 2021 her3-dxd dato-dxd sacituzumab govitecan pertuzumab non-hodgkin's lymphoma s1pr modulator s1pr s1p tolebrutinib sopain2018 southern pain society pain jump hypertrophic cardiomyopathy soho18 hcm obstructive hypertrophic cardiomyopathy nonobstructive hypertrophic cardiomyopathy ashmhm18 cardiomyopathies mavacamten hospitalist ifi invasive fungal infections mdd obesity management aficamten scleroderma phaware cteph pah ripretinib avapritinib gists ctos2020 tyrosine kinase inhibitors gist sarcomas posterior circulation stroke intravitreal anti-vegf treatments optometry arthritis type2inflammation atopicdisease oacs immunotherapy combinations hepatocellular aasld systemic sclerosis alzheimers covid-19 treatment screening steroidal mras steroidal mineralocorticoid receptor antagonists nonsteroidal mineralocorticoid receptor antagonist nonsteroidal mras mras mineralocorticoid receptor antagonists dkd end-stage kidney disease kidney disease dabrafenib trametinib capmatinib b-cell acute lymphoblastic leukemia flaura neurofibromatosis type 1 tuberous sclerosis complex iron therapy iron deficiency hfpef heart failure with preserved ejection fraction heart failure with reduced ejection fraction hfref next-generation sequencing please visit us at https://bit.ly/2rswhfh. cme/moc 2023. optic pathway gliomas hep c sleep medicine sodium oxybate lower-sodium oxybate modafinil methylphenidate pitolisant psoriaticdisease astro17 ais acute ischemic stroke ramucirumab spondyloarthritis nr-axspa ntrk pelvic pain women’s health #peerview pdl1 esophagogastric cancer surgeons #peerview #esophagealcancer #peerview #cme esophageal squamous cell carcinoma matthew d. galsky chronic spontaneous urticaria diagnosis realworldevidence realworlddata discusses bladder cancer in this cme/moc activity onsbridge targeted- let'swin anti–pd-1 therapy and antibody-based models for patient care.” for t downloadable practice aids acute lymphocytic leukemia antiangiogenic antiangiogenesis monograph and complete cme/moc information #lungcancer msi-h/dmmr tumor mutational burden anti-vegf therapy t1dm secukinumab ixekizumab nonradiographic axial spondyloarthritis mhspc nmcrpc tmb crsnp rock2 inhibitors acute gvhd chronic gvhd immunosuppression kidney transplantation precision immunooncology cemiplimab ca224-047 pivot nktr-214 bempegaldesleukin diagnostic radiology hepatic/biliary disorders thrombosis nusinersen onasemnogene abeparvovec-xioi alzheimer’s disease direct-acting oral anticoagulants telehealth telemedicine nonvalvular af af antidepressants postpartum depression risdiplam newborn sma screening immunotherapies msi/mmr msi-h vitreoretinal surgery laser therapy corticosteroid implants dmmr myeloid cancer myelodysplastic syndrome alectinib bleeding anticoagulant reversal annexa-4 annexa-r annexa-a re-verse ad prothrombin complex concentrate idarucizumab andexanet alfa doac reversal gi bleeding washout contraception breastfeeding family planning pregnancy disease-modifying finerenone eplerenone relatlimab lag-3 bempeg syd895 maintenance u3-1402 hemophilia a general medicine neovascular gastriccancer colorectalcancer pancreaticcancer gicsm gicancer projectecho btk inhibition hematologic malignancies eczema mpnsm ezh2 inhibitors adjuvant immunotherapy neoadjuvant immunotherapy asthma endotypes low grade glioma al amyloidosis unresectable melanoma tumor-infiltrating lymphocytes transcription inhibitor flu ctcae myelosuppression tctm20 ls-sclc glioma hepc graft versus host disease jak inhibitor hr+ breast cancer calcineurin inhibitor post-transplant cyclophosphamide ashp19 dna damage response pathway ddr mutations ddr mutant ddr neutropenia myeloid growth factors biosimilars mm combination therapy antiangiogenic therapy biologic therapy actrims pi3k inhibitor mek inhibitor neoadjuvant/adjuvant settings light chain amyloidosis optic pathway glioma biologic therapies insomnia personalized medicine ded dry eye disease steroid-sparing anti–il-5 bariatric surgery asmbs 2021 novel antibodies wm waldenström’s macroglobulinemia mzl newly diagnosed multiple myeloma relapsed multiple myeloma bcr antibody real-world evidence xpo1 inhibitor proteasome inhibitors asthma phenotypes allohct rucaparib oncology gynecologic oncology dna repair deficiency gi cancer targeted therapies lungevity anti-obesity medication cartcell orlistat stroma-targeting agents hepatcocellular carcinoma phentermine/topiramate er naltrexone er/bupropion er immunotherapy-tki intrahepatic cholangiocarcinoma cc meded brca mutations csf1 cardiometabolic csf1r cme/moc/cc ada 2020 ribociclib abemaciclib pexidartinib palbociclib cdk inhibitor cdk4 and 6 inhibitors t-dm1 trastuzumab deruxtecan tucatinib sodium polystyrene sulfonate patiromer spironolactone #moleculartesting #oncology #nsclc natriuretic peptides cvrisks nt-probnp aha2019 bnp lgg tenosynovial giant cell tumor #coronavirusdisease connective tissue tumor #covid #covid19 advanced prostate cancer brain tumors cme/moc/cne asmd uveitis basal cell carcinoma antibody-drug conjugates pi3k mtor inhibitor homologous recombination deficient homologous recombination deficiency hrd homologous recombination repair hrr akt inhibitor hr dna damage response pathways dna repair defects glp-1 receptor agonists sodium zirconium cyclosilicate ectrims2019 aats2020 potassium binders dmts hospital medicine gastroesophageal junction care coordination pcsk9 io-io sno2019 familypractice castration-resistant prostate cancer metastatic prostate cancer t-cell parkinson's psychosis pcsm pd psychosis egfr-targeted therapy cutaneous t-cell lymphoma aes2017 antipsychotics acep17 bcan sitc2017 parkinson's pd cutaneous lymphoma cancer immunotherapy abuse-deterrent opioids psychosis blcsm migraines eadvgen eadv aua17 egfr mutation sts ctos american academy of neurology aan 2017 connective tissue oncology society chest 2017 hcc17 hfsa2017 ow2017 cancer care patient outcomes colorectal european academy of allergy and clinical immunolog bipolar depression bipolar disorder immune checkpoint adverse effects eaaci2017 chicagolung17 eaaci nasal polyps cmsc17 psoriatic arthritis psa obesity week 2017 astro 2017 shared decision making stem cell aua american academy of urology merkel cell carcinoma carcinoma vod/sos pv chronic obstructive pulmonary disease cap17dc cap cap17 quality improvement qi hematopoietic stem cell transplant solid organ transplant skin cancer advanced pancreatic cancer pulmonary rehabilitation idweek her2-postive myelodysplastic cml idweek2017 cd30-expressing the liver meeting medicine livermtg17 physiotherapy respiratory therapy chronic heart failure aasm overweight bmi body mass index glp-1 ras for obesity metabolic adaptation obesity pathophysiology exenatide er exenatide bid glycemic benefits nonglycemic benefits pleiotropic effects glucagon-like peptide 1 receptor agonists glucagon-like peptide 1 individualized treatment plans diabetes care antiviral therapy neuraminidase inhibitors oseltamivir peramivir zanamivir polymerase complex inhibitor baloxavir capstone-1 capstone-2 ministone-2 blockstone myelodysplasia-related changes mrc cpx-351 cytarabine dextroamphetamine solriamfetol multiple sleep latency test mslt polysomnography psg chronicfibrosinginterstitiallungdisease cfild chronichypersensitivitypneumonitis chp connectivetissuedisease ctd hypersensitivitypneumonitis hp idiopathicinterstitialpneumonia iip idiopathicnonspecificinterstitialpneumonia insip idiopathicpulmonaryfibrosis mixedconnectivetissuedisease pompedisease hemophilia b rna interference sirna nonfactor therapies cd38 antibodies parkinson’s disease idiopathic hypersomnia clarithromycin spesolimab ox40l anti-ox40 european academy of dermatology and venereology eadv 2021 30th european academy of dermatology and venereolo eoe cendakimab ueg acg jonathan a. bernstein prepared useful practice aids pertaining to chroni please visit us at https://bit.ly/3rxtkqc. cme cre 2022. small cell lymphoma waldenstrom macroglobulinemia b-cell cancers covalent btk inhibitors noncovalent btk inhibitors etokimab ar101 tnx-901 palisade outmatch carboplatin/paclitaxel carboplatin/paclitaxel/trastuzumab molecular classification cold tumors hot tumors copy number-high tumors sleep 2021 daunorubicin azacitidine decitabine ats gina global initiative for asthma tezepelumab multikinase biliary cancer von willebrand disease von willebrand factor vwd vwf desmopressin ddavp humate p alphanate wilate wilfactin vonvendi moderate to severe atopic dermatitis type 2 inflammation eftad/eadv eczema task force anti–il-4rα tralokinumab anti–il-13 lebrikizumab nemolizumab supranuclear attr attr amyloidosis amyloid hereditary attr amyloidosis hattr amyloidosis pneumonia interstitial pneumonia lung disease idiopathic pumonary fibrosis fibrosis usual interstitial pneumonia detemir nph degludec glargine glp1 glp1ra rhinosiusitis nasal polpys lcfaod extrahepatic cholangiocarcinoma slide share activi extrahepatic cholangiocarcinoma hepatic and biliary disorders nash nafld bone marrow transplant hypoglycemia dermatitis interleukin-4 cln2 neuronal ceroid lipofuscinoses ash2017 msparis2017 glp-1 agonist american society of hematology ash short bowel syndrome intestinal failure parenteral nutrition cidp chronic inflammatory demyelinating polyneuropathy bleeding disorders immunosym growth hormone deficiency ghd lysosomal storage disease fabry disease mps vii sly syndrome eukemia spondylitis orthopedics ddw ematology pompe disease scalp psoriasis sglt2 iron deficienct real-world studies rcts major bleeding cancer-associated vte apixaban rivaroxaban edoxaban alopecia areata polyarticular juvenile idiopathic arthritis juvenile idiopathic arthritis acute hepatic porphyria ahp rare diseases sirna therapy abdominal pain emergencymedicine nonvalvularatrialfibrillation venousthromboembolism tp53 cd47 antibodies renal cancer narcolepsy cataplexy type 1 narcolepsy type 2 narcolepsy excessive daytime sleepiness eds sleep armodafinil anti–il-31rα psp interleukin-13 pde-4 inhibitors cancer biomarkers sma s anti-angiogensis american society of clinical oncology annual meeti rheumatoidarthritis jakinhibitors rheumaticdisease stroke guidelines stroke guidelines pharmacotherapy 5-ht1f agonists sglt2i hemodialysis potassium binder thyroidcancer precisionmedicine ret fungal chronicrhinosinusitis nasalpolyps topoisomerase i inhibitor tubulin targeter prodrug irinotecan temozolomide multiplesclerosis vascular medicine direct acting oral anticoagulants